Abbreviated Name

Prostate Rapid Ref Set App: Chan/Beckman (2007)

Lead Investigator

Chan, Daniel — Johns Hopkins Medical Institutions

Coordinating Investigator

Feng, Ziding — Fred Hutchinson Cancer Center

Involved Investigators

• Feng, Ziding — Fred Hutchinson Cancer Center
• Chan, Daniel — Johns Hopkins Medical Institutions
• Srivastava, Sudhir — National Cancer Institute

Abstact

Aims

Evaluate performance of [-2]proPSA as an early detection marker for prostate cancer

Analytic Method

Specimens were analyzed in a blinded fashion at Beckman Coulter, Inc. on the Beckman Coulter ACCESS 2 immunoassay system for PSA, free PSA, [-2]proPSA, BPSA and testosterone. The PSA assays are all dual monoclonoal sandwich assays using Hybritech antibodies and chemiluminescent detection system. The assays for PSA, free PSA and testosterone are commercially available which the assays for [-2]proPSA and BPSA are for research use only.

Biomarkers

• BPSA
• fPSA
• proPSA
• PSA
• Testosterone

Data Collections

• No data available at this time for this protocol

 Team Project

Protocol ID

284

Field of Research

Proteomics

Collaborative Group

Prostate and Urologic Cancers Research Group

Cancer Types

• Malignant neoplasm of prostate

Phased Status

1